• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON LABORATORIES IRELAND LTD. CLAREON IOL; INTRAOCULAR LENS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON LABORATORIES IRELAND LTD. CLAREON IOL; INTRAOCULAR LENS Back to Search Results
Model Number SY60WF
Medical Device Problem Code Scratched Material (3020)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 04/27/2022
Type of Reportable Event Malfunction
Event or Problem Description
An ophthalmologist reported that, following an intraocular lens (iol) implant procedure, optic of the iol found to be scratched.The surgery was performed and completed after replacing the product with another one.Additional information was received that, after insertion of the iol, a vertical white opacity was observed on the posterior surface of the iol.The iol was removed in three sections and a spare iol was inserted with the same injector and a different cartridge.The patient's postoperative course was good.
 
Additional Manufacturer Narrative
The product was returned for analysis.Investigation including root cause analysis is in progress.A supplemental mdr will be filed as necessary in accordance with 21 cfr 803.56 when additional reportable information becomes available.The manufacturer internal reference number is: (b)(4).
 
Additional Manufacturer Narrative
The product was returned for analysis and the reported damage was observed.Iol returned adhered to gauze in three pieces, in non-company sealed pouch.Solution is dried on both surfaces of the optic and haptics.Both haptics have gauze fiber adhered.The optic is cut in 3 (three) and scratched/marked-rejectable with adhered gauze fiber.The root cause for the reported complaint "scratch on optic" could not be determined.The returned iol shows evidence of possible handling by the customer due to the presence of solution dried on both surfaces of the optic and haptics.In addition to this, all iols are 100% cosmetically inspected as per approved manufacturing procedures and the observed lens damage would not meet our current release criteria.Based on these investigation findings, we are unable to verify if the iol contributed to the event.The product history records confirm that the product met release criteria.There have been no other complaints for this lot.The manufacturer internal reference number is: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CLAREON IOL
Common Device Name
INTRAOCULAR LENS
Manufacturer (Section D)
ALCON LABORATORIES IRELAND LTD.
cork business&technology park
model farm road
cork 00000
EI  00000
Manufacturer (Section G)
ALCON LABORATORIES IRELAND LTD.
cork business&technology park
model farm road
cork 00000
EI   00000
Manufacturer Contact
jonathan schlech
6201 south freeway
mail stop ab2-6
fort worth, TX 76134
8007579780
MDR Report Key14485657
Report Number9612169-2022-00235
Device Sequence Number20164182
Product Code HQL
UDI-Device Identifier00380652251426
UDI-Public00380652251426
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
P190018
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 08/16/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date02/29/2024
Device Model NumberSY60WF
Device Lot Number21286171
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 04/27/2022
Supplement Date Received by Manufacturer07/22/2022
Initial Report FDA Received Date05/24/2022
Supplement Report FDA Received Date08/16/2022
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured11/03/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
MONARCH III IOL CARTRIDGE D; MONARCH IV IOL INJECTOR
Patient Age67 YR
Patient SexUnknown
-
-